Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

has now listed Novo Nordisk’s blockbuster diabetes and obesity medications Wegovy and Ozempic as “available.” Semaglutide ...

Osteoarthritis, the most common form of arthritis, is primarily caused by wear and tear on the protective layer of cartilage ...

After years in shortage, weight loss and diabetes drugs Ozempic and Wegovy are now considered to be “available” by the Food ...

Problem-focused strategies which directly addressing diabetes management. The most frequently used and perceived as useful ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy ...

The latest celebrity weight-loss drug to be given the nod in Hong Kong will be available in December, but experts cautioned ...

Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including ...

US Food and Drug Administration (FDA) regulations allow human drug compounding — in which licensed pharmacists or physicians can combine, mix, or adjust the ingredients of a medication — to meet ...

Other diabetes drugs, specifically sodium-glucose cotransporter ... In fact, semaglutide topped a list of drug spending in ...

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked ...

This World Diabetes Day, experts stress that finding the right plan is essential for ensuring a secure, proactive approach to ...